Humana Inc. (NYSE:HUM) Shares Bought by Leith Wheeler Investment Counsel Ltd.

Leith Wheeler Investment Counsel Ltd. raised its position in shares of Humana Inc. (NYSE:HUM - Free Report) by 1.9% in the 4th quarter, according to the company in its most recent disclosure with the SEC. The fund owned 127,592 shares of the insurance provider's stock after buying an additional 2,390 shares during the quarter. Humana comprises about 2.3% of Leith Wheeler Investment Counsel Ltd.'s investment portfolio, making the stock its 12th largest holding. Leith Wheeler Investment Counsel Ltd. owned approximately 0.11% of Humana worth $32,371,000 at the end of the most recent reporting period.

A number of other institutional investors and hedge funds have also recently modified their holdings of HUM. FPC Investment Advisory Inc. acquired a new stake in Humana in the fourth quarter worth about $27,000. Centricity Wealth Management LLC acquired a new stake in Humana in the 4th quarter worth approximately $30,000. LFA Lugano Financial Advisors SA grew its position in Humana by 56.3% during the 4th quarter. LFA Lugano Financial Advisors SA now owns 125 shares of the insurance provider's stock worth $32,000 after purchasing an additional 45 shares during the last quarter. OFI Invest Asset Management acquired a new position in Humana during the 4th quarter valued at approximately $33,000. Finally, Transce3nd LLC acquired a new position in Humana during the 4th quarter valued at approximately $38,000. Hedge funds and other institutional investors own 92.38% of the company's stock.

Analyst Ratings Changes

A number of equities research analysts have recently weighed in on HUM shares. Barclays boosted their price objective on shares of Humana from $270.00 to $322.00 and gave the company an "equal weight" rating in a report on Friday, April 11th. Robert W. Baird lifted their price target on Humana from $270.00 to $300.00 and gave the stock a "neutral" rating in a research report on Tuesday, April 15th. Oppenheimer raised their price objective on Humana from $300.00 to $310.00 and gave the stock an "outperform" rating in a research note on Thursday. Piper Sandler upped their target price on Humana from $270.00 to $288.00 and gave the company a "neutral" rating in a research report on Wednesday, January 15th. Finally, Raymond James raised shares of Humana from a "market perform" rating to an "outperform" rating and set a $315.00 price target for the company in a research report on Thursday. Eighteen investment analysts have rated the stock with a hold rating and seven have issued a buy rating to the stock. Based on data from MarketBeat.com, Humana presently has an average rating of "Hold" and an average target price of $287.76.

Humana Price Performance

Shares of NYSE:HUM traded up $2.17 during midday trading on Friday, hitting $258.21. The company had a trading volume of 1,740,020 shares, compared to its average volume of 1,753,030. The business's 50-day simple moving average is $266.17 and its 200-day simple moving average is $270.73. The stock has a market cap of $31.16 billion, a price-to-earnings ratio of 25.95, a price-to-earnings-growth ratio of 2.05 and a beta of 0.49. The company has a debt-to-equity ratio of 0.68, a current ratio of 1.76 and a quick ratio of 1.76. Humana Inc. has a twelve month low of $213.31 and a twelve month high of $406.46.

Humana (NYSE:HUM - Get Free Report) last posted its quarterly earnings results on Wednesday, April 30th. The insurance provider reported $11.58 EPS for the quarter, topping the consensus estimate of $10.07 by $1.51. Humana had a return on equity of 11.70% and a net margin of 1.02%. The business had revenue of $32.11 billion for the quarter, compared to analyst estimates of $32 billion. During the same quarter in the previous year, the firm earned $7.23 EPS. The company's quarterly revenue was up 8.4% compared to the same quarter last year. On average, research analysts predict that Humana Inc. will post 16.47 earnings per share for the current year.

Humana Announces Dividend

The company also recently declared a quarterly dividend, which will be paid on Friday, July 25th. Stockholders of record on Friday, June 27th will be paid a $0.885 dividend. The ex-dividend date is Friday, June 27th. This represents a $3.54 annualized dividend and a dividend yield of 1.37%. Humana's dividend payout ratio (DPR) is 25.04%.

About Humana

Humana Inc, together with its subsidiaries, provides medical and specialty insurance products in the United States. It operates through two segments, Insurance and CenterWell. The company offers medical and supplemental benefit plans to individuals. It has a contract with Centers for Medicare and Medicaid Services to administer the Limited Income Newly Eligible Transition prescription drug plan program; and contracts with various states to provide Medicaid, dual eligible, and long-term support services benefits.